The diagnosis of cannabis dependence

Cannabis Dependence: Its Nature, Consequences, and Treatment

Volumn , Issue , 2006, Pages 21-36

  Babor, Thomas F ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927113934     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544248.004     Document Type: Chapter

References (39)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders(4th ed.). Washington, DC: American Psychiatric Association.
2. Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.
3. Babor, T. F. (1992). Nosological considerations in the diagnosis of substance use disorders. In M. Glantz, & R. Pickens (Eds.), Vulnerability to drug abuse(pp. 53–73). Washington, DC: American Psychological Association.
4. Babor, T. F. (1995). The road to DSM-IV: confessions of an erstwhile nosologist. Drug and Alcohol Dependence, 38, 75–79.
5. Babor, T. F., Mendelson, J. H., Greenberg, I., & Kuehnle, J. C. (1975). Marihuana consumption and tolerance to physiological and subjective effects. Archives ofGeneral Psychiatry, 32, 1548–1552.
6. Budney, A. J., Novy, P. L., & Hughes, J. R. (1999). Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction, 94, 1311–1321.
7. Crowley, T. J., Macdonald, M. J., Whitmore, E. A., & Mikulich, S. K. (1998). Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug and Alcohol Dependence, 50, 27–37.
8. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946–1949.
9. Easton, C., Meza, E., Mager, D., Ulug, B., Kilic, C., Gogus, A., et al. (1997). Test-retest reliability of the alcohol and drug use disorder sections of the schedules for clinical assessment in neuropsychiatry (SCAN). Drug and Alcohol Dependence, 47, 187–194.
10. Edwards, G., Arif, A., & Hodgson, R. (1981). Nomenclature and classification of drug- and alcohol-related problems: a WHO memorandum. Bulletin of the World HealthOrganization, 59, 225–242.
11. Gardner, E., & David, J. (1999). The neurobiology of chemical addiction. In J. Elster, & O. J. Skog (Eds.), Getting hooked: rationality and addiction(pp. 93–136). Cambridge, UK: Cambridge University Press.
12. Gruber, A. J., & Pope, H. G. (1997). Cannabis-related disorders. In A. Tasman, J. Kay, & J. A. Liberman (Eds.), Psychiatry(Vol. 1, pp. 795–806). Philadelphia, PA: WB Saunders Company.
13. Hall, W., Johnston, L., & Donnelly, N. (1999). Epidemiology of cannabis use and its consequences. In H. Kalant, W. A. Corrigal, W. A. Hall, & R. Smart (Eds.), The healtheffects of cannabis(pp. 71–125). Toronto, Ont. Addiction Research Foundation.
14. Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology, 141, 395–404.
15. Inciardi, J. A. (1994). Screening and assessment for alcohol and other drug abuse among adults in the criminal justice system. Treatment improvement protocol(TIP) series7, DHHS Publication No. (SMA) 94B2076. Rockville, MD: Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration.
16. Jones, R. T., Benowitz, N., & Bachman, J. (1976). Clinical studies of tolerance and dependence. Annals of the New York Academy of Sciences, 282, 221–239.
17. Kandel, D. C., & Davies, M. (1992). Progression to regular marijuana involvement: phenomenology and risk factors for near daily use. In M. Glantz, & R. Pickents (Eds.), Vulnerability to drug abuse(pp. 211–253). Washington, DC: American Psychological Association.
18. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
19. Kranzler, H. R., Kadden, R. M., Babor, T. F., Tennen, H., & Rounsaville, B. J. (1996). Validity of the SCID in substance abuse patients. Addiction, 91, 859–868.
20. Kranzler, H. R., Tennen, H., Babor, T. F., Kadden, R. M., & Rounsaville, B. J. (1997). Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. Drug and Alcohol Dependence, 45, 93–104.
21. Marijuana Treatment Project Research Group (2004). Brief treatments for cannabis dependence: findings from a randomized multi-site trial. Journal of Consultingand Clinical Psychology, 72, 455–466.
22. Mendelson, J., Mello, N., Lex, B., & Bavli, S. (1984). Marijuana withdrawal syndrome in a woman. American Journal of Psychiatry, 141, 1289–1290.
23. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., et al. (1994). SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. Federation of European Biochemical Societies Letters, 350, 240–244.
24. Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., & Burke, J. (1988). The Composite International Diagnostic Interview: an epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45, 1069–1077.
25. Rosenberg, M. F., & Anthony, J. C. (2001). Early clinical manifestations of cannabis dependence in a community sample. Drug and Alcohol Dependence, 64, 123–131.
26. Rounsaville, B. J., Tims, F. M., Horton Jr., A. M., & Sowder, B. J. (Eds.) (1993a) Diagnostic source book on drug abuse research and treatment. Rockville, MD: National Institute on Drug Abuse.
27. Rounsaville, B. J., Bryant, K., Babor, T., Kranzler, H., & Kadden, R. (1993b). Cross system agreement for substance use disorders: DSM-II-R, DSM-IV and ICD-10. Addiction, 88, 337–348.
28. Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1988). Instruction manual for the structural clinical interview for DSM-III-R. New York: BiometricsResearch.
29. Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1993). Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology, 61, 1100–1104.
30. Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1994). Treating adult marijuana dependence: a test of the relapse prevention model. Journal of Consulting andClinical Psychology, 62, 92–99.
31. Stephens, R. S., Roffman, R. A., & Curtin, L. (2000). Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898–908.
32. Stephens, R. S., Babor, T. F., Kadden, R., Miller, M., The Marijuana Treatment Project Research Group (2002). The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction, 97(Suppl. 1), 109–124.
33. Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2002). Treatment Episode Data Set (TEDS): 1992–2000. National admissions to substance abuse treatment services, DASIS Series: S-17, DHHS publication No. (SMA) 02-3727. Rockville, MD: Office of Applied Studies.
34. Swift, W., Copeland, J., & Hall, W. (1998). Choosing a diagnostic cut-off for cannabis dependence. Addiction, 93, 1681–1692.
35. Weisbeck, G. A., Schuckit, M. A., Kalmijn, J. A., Tipp, J. E., Bucholz, K. K., & Smith, T. L., et al. (1996). An evaluation of the history of marijuana withdrawal syndrome in a large population. Addiction, 91, 1469–1478.
36. Wing, J. K., Babor, T., Brugha, T., Burke, J., Cooper, J. E., Giel, R., et al. (1990). SCAN –Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry,47, 589–593.
37. Wolff, K., Farrell, M., Marsden, J., Monteiro, M. G., Ali, R., Welch, S., et al. (1999). A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction, 94, 1279–1298.
38. World Health Organization (1992). The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva, Switzerland:World Health Organization.
39. World Health Organization (1993). The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva, Switzerland: World HealthOrganisation.